First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 6.5% of the 7,921 shares held after it.
No other insider sold within 30 days.
Insider activity: GC & CORPORATE SECRETARY GILBERT EDWARD TERRELL JR sold about $18.6K of ASTE on May 1, 2025, the largest insider sale at the company since 2021.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 2.7% of the 73,878 shares held after it.
1 other insider bought within 30 days.
Insider activity: Chief Executive Officer Merwe Jaco van der bought about $67.4K of ASTE on May 16, 2024, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 6.3% of the 15,886 shares held after it.
1 other insider bought within 30 days.
Insider activity: GROUP PRESIDENT NORRIS MICHAEL PAUL bought about $33.5K of ASTE on May 8, 2024, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.
7 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
ASTE planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Barry ARuffalo
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2022
$4.2M
$1.0M
$1.2M
-0%
+28%
2021
$3.5M
$4.3M
$1.2M
+68%
+41%
2020
$2.7M
$4.7M
$1.1M
+39%
+12%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.6B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ASTE
FY Dec 2025
$1.4B
FY Dec 2024
$1.3B
FY Dec 2023
$1.3B
FY Dec 2022
$1.3B
FY Dec 2021
$1.1B
Jun 2026
$408.1M
Mar 2026
$396.3M
Dec 2025
$400.6M
Sep 2025
$350.1M
Jun 2025
$330.3M
Mar 2025
$329.4M
Dec 2024
$359.0M
Sep 2024
$291.4M
At each fiscal year end
Single quarter
Net margin, TTM
+1.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ASTE
FY Dec 2025
+2.8%
FY Dec 2024
+0.3%
FY Dec 2023
+2.5%
FY Dec 2022
-0.0%
FY Dec 2021
+1.4%
Jun 2026
+2.6%
Mar 2026
+0.3%
Dec 2025
+3.0%
Sep 2025
-1.2%
Jun 2025
+5.1%
Mar 2025
+4.3%
Dec 2024
+5.9%
Sep 2024
-2.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
$32.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ASTE
FY Dec 2025
$20.7M
FY Dec 2024
$2.5M
FY Dec 2023
-$6.3M
FY Dec 2022
-$114.6M
FY Dec 2021
-$12.7M
Jun 2026
$4.7M
Mar 2026
$32.6M
Dec 2025
$7.4M
Sep 2025
-$12.3M
Jun 2025
$9.0M
Mar 2025
$16.6M
Dec 2024
$32.1M
Sep 2024
$19.9M
At each fiscal year end
Single quarter
Debt to equity
0.55x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity ASTE
FY Dec 2025
0.49x
FY Dec 2024
0.16x
FY Dec 2023
0.11x
FY Dec 2022
0.12x
FY Dec 2021
0.00x
Jun 2026
0.55x
Mar 2026
0.56x
Dec 2025
0.49x
Sep 2025
0.51x
Jun 2025
0.02x
Mar 2025
0.02x
Dec 2024
0.16x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.21x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt ASTE
FY Dec 2025
0.18x
FY Dec 2024
0.22x
FY Dec 2023
0.39x
FY Dec 2022
-0.94x
FY Dec 2021
24.67x
Jun 2026
0.21x
Mar 2026
0.21x
Dec 2025
0.18x
Sep 2025
0.18x
Jun 2025
6.51x
Mar 2025
6.56x
Dec 2024
0.22x
Sep 2024
22.00x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ASTE
FY Dec 2025
+5.9%
FY Dec 2024
+0.7%
FY Dec 2023
+5.2%
FY Dec 2022
-0.0%
FY Dec 2021
+2.4%
Jun 2026
+2.9%
Mar 2026
+3.9%
Dec 2025
+5.9%
Sep 2025
+7.4%
Jun 2025
+7.0%
Mar 2025
+2.3%
Dec 2024
+0.7%
Sep 2024
-0.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ASTE
FY Dec 2025
+3.2%
FY Dec 2024
+0.4%
FY Dec 2023
+3.2%
FY Dec 2022
-0.0%
FY Dec 2021
+1.8%
Jun 2026
+1.6%
Mar 2026
+2.1%
Dec 2025
+3.2%
Sep 2025
+4.0%
Jun 2025
+4.2%
Mar 2025
+1.4%
Dec 2024
+0.4%
Sep 2024
-0.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+3.7%
operating income after a 31.8% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital ASTE
FY Dec 2025
+5.3%
FY Dec 2024
n/a
FY Dec 2023
+5.9%
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
+3.7%
Mar 2026
+4.0%
Dec 2025
+5.3%
Sep 2025
+5.9%
Jun 2025
+8.3%
Mar 2025
+3.3%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+5.7%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed ASTE
FY Dec 2025
+7.3%
FY Dec 2024
+3.0%
FY Dec 2023
+6.5%
FY Dec 2022
+1.1%
FY Dec 2021
+2.9%
Jun 2026
+5.7%
Mar 2026
+5.9%
Dec 2025
+7.3%
Sep 2025
+8.7%
Jun 2025
+8.8%
Mar 2025
+4.7%
Dec 2024
+3.0%
Sep 2024
+0.9%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
45.25x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ASTE
FY Dec 2025
25.79x
FY Dec 2024
168.00x
FY Dec 2023
25.31x
FY Dec 2022
n/a
FY Dec 2021
101.87x
Jun 2026
71.99x
Mar 2026
48.07x
Dec 2025
25.79x
Sep 2025
23.03x
Jun 2025
20.84x
Mar 2025
51.42x
Dec 2024
168.00x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.2B
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value ASTE
FY Dec 2025
$1.3B
FY Dec 2024
$780.3M
FY Dec 2023
$854.8M
FY Dec 2022
$935.8M
FY Dec 2021
$1.4B
Jun 2026
$1.7B
Mar 2026
$1.5B
Dec 2025
$1.3B
Sep 2025
$1.4B
Jun 2025
$878.8M
Mar 2025
$706.8M
Dec 2024
$780.3M
Sep 2024
$674.5M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.7%
TTM free cash flow over market value at close 2026-10-27
FCF yield ASTE
FY Dec 2025
+2.1%
FY Dec 2024
+0.3%
FY Dec 2023
-0.7%
FY Dec 2022
-12.4%
FY Dec 2021
-0.8%
Jun 2026
+2.3%
Mar 2026
+3.0%
Dec 2025
+2.1%
Sep 2025
+4.1%
Jun 2025
+8.1%
Mar 2025
+9.2%
Dec 2024
+0.3%
Sep 2024
+1.1%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -57%, PEG needs growth
PEG, trailing ASTE
FY Dec 2025
0.03x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
0.72x
Dec 2025
0.03x
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
ASTE ranks highest on risk and compliance (61st percentile) and growth (60th), and lowest on profitability (31st), among Industrials peers.
Profitability
31
Inputs
Return on equity+2.9% · 34 pct, sector of 198
Return on assets+1.6% · 40 pct, sector of 224
Return on invested capital+3.7% · 8 pct, sector of 107
Return on capital employed+5.7% · 42 pct, sector of 195
Financial health
39
Inputs
Debt to equity0.55x · 38 pct, sector of 215
Cash flow to debt0.21x · 40 pct, sector of 173
Growth
60
Inputs
Revenue growth, YoY+8.1% · 60 pct, sector of 255
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
61
Inputs
Short interest, % of float+2.7% · 65 pct, sector of 271
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 192
New text in Risk Factors, latest 10-K+22.1% · 17 pct, sector of 197
3 not measured: Insider conviction, Institutional and government, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.